Exchange: NASDAQ·Updated 07:30 PM EDT

About GLMD

About

Eocene Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
6

Frequently Asked Questions

What is Market Cap of Eocene Ltd.?
What is the 52-week high for Eocene Ltd.?
What is the 52-week low for Eocene Ltd.?
What is Eocene Ltd. stock price today?
What was Eocene Ltd. stock price yesterday?
What is the PE ratio of Eocene Ltd.?
What is the Price-to-Book ratio of Eocene Ltd.?
What is the 50-day moving average of Eocene Ltd.?
How many employees does Eocene Ltd. have?

Advertisement|Remove ads.